A Phase II, Open-label study to assess safety and management change using 68Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
J Nucl Med
; 2021 Mar 19.
Article
en En
| MEDLINE
| ID: mdl-33741648
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Idioma:
En
Revista:
J Nucl Med
Año:
2021
Tipo del documento:
Article
País de afiliación:
Reino Unido